Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
In this interactive case study, you will prepare for a tumor board discussion that will determine whether your patient is a candidate for biomarker testing and eligible for biomarker-directed therapy.
Review the growing role of biomarker testing in personalized cancer care with expert Dr. Danielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP. She will present three case studies that highlight biomarker testing work-up, implication for patient care, and patient education.
Explaining the complex biomarker testing process to your patients can be made simple by utilizing the Biomarker Testing in Non-Small Cell Lung Cancer Discussion Tool to guide this conversation with your patients. It provides patient friendly language to describe biomarker testing and the why, when, and how of the process. It also gives the patient space to write notes and capture their cancer’s biomarkers.
Learn more about best practices for personal protective equipment during administration, compounding, and spill management of checkpoint inhibitors.
Intentional, facilitated conversations are opportunities for healthcare staff to gather outside of patient care, meetings with agendas, or formal conferences.
Oncology nursing is a meaningful profession and your many actions as an oncology nurse make a difference every day.
Explains the mechanism of action or CDK4/6 inhibitor, a targeted therapy used in the treatment of HR+, HER2- metastatic breast cancer.
After your patient is prescribed a CDK4/6 inhibitor, use this video to ensure that you have completed the appropriate initial assessment and tests.